603222.SH
济民健康
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 8.06
−1.95%Year over year
Reported trailing growth
- Revenue
- -7.6%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -6.4%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -15.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026